Cohen A, O'Grady J, Mowat A, Williams R
Baillieres Clin Gastroenterol. 1989 Oct;3(4):767-86. doi: 10.1016/0950-3528(89)90031-6.
Liver transplantation for metabolic disorders continues to be an expanding field, both in the range of indications and patient numbers. In most large series it accounts for approximately 7% of all adult transplants and 29% of all childhood transplants. As the results of medical therapy are improved so too are the results of liver transplantation, and hence more patients are being considered for the latter therapy. The benefits of this treatment are not only the prolongation of and improvement in the quality of life for the patient, it has also given insight into the basic metabolic defects of many disorders.
用于治疗代谢紊乱的肝移植领域不断扩大,无论是适应证范围还是患者数量都在增加。在大多数大型系列研究中,它约占所有成人移植手术的7%,占所有儿童移植手术的29%。随着药物治疗效果的改善,肝移植的效果也得到了提高,因此越来越多的患者被考虑接受后者治疗。这种治疗的益处不仅在于延长了患者的生命并提高了生活质量,还使人们深入了解了许多疾病的基本代谢缺陷。